Forward Pharma files further submissions in proceeding for '355 patent
Forward Pharma A/S announced the filing of further written submissions in the European Opposition Proceeding for the EP2801355 patent with the Opposition Division of the European Patent Office. The filing will become publicly available via the European Patent Register. An oral hearing is currently scheduled for January 29-30, 2018. The Opposition Division typically issues a decision at the conclusion of the oral hearing, with more detailed reasons for the decision being issued in written form later. There is the possibility to appeal the decision of the Opposition Division to the Technical Board of Appeal, with an expected duration of the appeal process of an additional 2-3 years.